Probiotics and synbiotics targeting the intestinal microbiome attenuate non-alcoholic fatty liver disease
Hepatobiliary Surg Nutr
.
2020 Aug;9(4):526-529.
doi: 10.21037/hbsn.2019.11.24.
Authors
Luis Vitetta
1
2
,
Jeremy D Henson
2
3
Affiliations
1
Faculty of Medicine and Health, Sydney School of Medicine, The University of Sydney, Sydney, Australia.
2
Medlab Clinical Sydney, Sydney, Australia.
3
Faculty of Medicine, Prince of Wales Clinical School, University of New South Wales, Sydney, Australia.
PMID:
32832510
PMCID:
PMC7423537
DOI:
10.21037/hbsn.2019.11.24
No abstract available
Publication types
Editorial
Comment